Abstract
AIDS, the fatal disease, caused in human by the fast spreading human immunodeficiency virus (HIV), was detected in 1981. To check its rapid growth, affecting various parts of the world population, there are various FDA approved drugs, released in the market for treating AIDS. These belong to 5 different categories which differ in their mechanism of action. These are i) reverse transcriptase inhibitors, ii) protease inhibitors, iii) fusion inhibitors, iv) entry inhibitors and v) HIV integrase strand transfer inhibitors. These drugs are mostly used in a combination therapy, named as Highly Active Anti Retroviral Therapy (HAART), using 2 to 3 compounds in combination, for a more effective and beneficial treatment. However, none of the drugs can be considered ideal for curing the disease. A study of structural requirement for different types of anti-HIV activities may help in designing a suitable drug for AIDS.
Keywords: Anti HIV, AIDS, protease inhibitor, reverse transcriptase inhibitor, integrase inhibitor, fusion inhibitor
Mini-Reviews in Medicinal Chemistry
Title: Drugs for AIDS
Volume: 10 Issue: 2
Author(s): S. Ray, Z. Fatima and A. Saxena
Affiliation:
Keywords: Anti HIV, AIDS, protease inhibitor, reverse transcriptase inhibitor, integrase inhibitor, fusion inhibitor
Abstract: AIDS, the fatal disease, caused in human by the fast spreading human immunodeficiency virus (HIV), was detected in 1981. To check its rapid growth, affecting various parts of the world population, there are various FDA approved drugs, released in the market for treating AIDS. These belong to 5 different categories which differ in their mechanism of action. These are i) reverse transcriptase inhibitors, ii) protease inhibitors, iii) fusion inhibitors, iv) entry inhibitors and v) HIV integrase strand transfer inhibitors. These drugs are mostly used in a combination therapy, named as Highly Active Anti Retroviral Therapy (HAART), using 2 to 3 compounds in combination, for a more effective and beneficial treatment. However, none of the drugs can be considered ideal for curing the disease. A study of structural requirement for different types of anti-HIV activities may help in designing a suitable drug for AIDS.
Export Options
About this article
Cite this article as:
Ray S., Fatima Z. and Saxena A., Drugs for AIDS, Mini-Reviews in Medicinal Chemistry 2010; 10 (2) . https://dx.doi.org/10.2174/138955710791185145
DOI https://dx.doi.org/10.2174/138955710791185145 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical and Molecular Perspectives of Monogenic Hypertension
Current Hypertension Reviews Regulation of Angiogenesis by the Kallikrein-Kinin System
Current Pharmaceutical Design Editorial [Hot Topic: Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets Executive (Guest Editor: Armen Yuri Gasparyan)]
Current Pharmaceutical Design Toll-Like Receptors and Inflammation in the CNS
Current Drug Targets - Inflammation & Allergy Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets An Inducible Expression System for Recombinant Sca Proteins with an Autotransporter Domain from <i>Orientia Tsutsugamushi in Escherichia coli</i>
Protein & Peptide Letters Dopamine Administration in Very Low Birth Weight Preterm Infants:Emerging Issues on Endocrine Effects
Current Pediatric Reviews Barker and Brenner: A Basis for Hypertension?
Current Hypertension Reviews Organic Antifungal Drugs and Targets of Their Action
Current Topics in Medicinal Chemistry Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry Novel Strategies for the Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Isometric Handgrip Effects on Hypertension
Current Hypertension Reviews The Crosstalk Between Insulin and Renin-Angiotensin-Aldosterone Signaling Systems and its Effect on Glucose Metabolism and Diabetes Prevention
Current Vascular Pharmacology A Paradigm Shift in the Development of Anti-Candida Drugs
Current Topics in Medicinal Chemistry Tachykinins and the Cardiovascular System
Current Drug Targets Aryltetralin-type Lignan of Podophyllum: A Comprehensive Review
The Natural Products Journal Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Current Pharmaceutical Design Current Understanding of Polymyxin B Applications in Bacteraemia/ Sepsis Therapy Prevention: Clinical, Pharmaceutical, Structural and Mechanistic Aspects
Anti-Infective Agents in Medicinal Chemistry Ethosomes as Novel Vesicular Carrier: An Overview of the Principle, Preparation and its Applications
Current Drug Delivery Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry